[go: up one dir, main page]

NL2000373A1 - Antibacteriele middelen. - Google Patents

Antibacteriele middelen.

Info

Publication number
NL2000373A1
NL2000373A1 NL2000373A NL2000373A NL2000373A1 NL 2000373 A1 NL2000373 A1 NL 2000373A1 NL 2000373 A NL2000373 A NL 2000373A NL 2000373 A NL2000373 A NL 2000373A NL 2000373 A1 NL2000373 A1 NL 2000373A1
Authority
NL
Netherlands
Prior art keywords
antibacterial agents
antibacterial
agents
Prior art date
Application number
NL2000373A
Other languages
English (en)
Other versions
NL2000373C2 (nl
Inventor
Allen Johnson Timothy
Debra Ann Sherry
Dennis Joseph Mcnamara
Peter Laurence Toogood
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL2000373(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL2000373A1 publication Critical patent/NL2000373A1/nl
Application granted granted Critical
Publication of NL2000373C2 publication Critical patent/NL2000373C2/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NL2000373A 2005-12-22 2006-12-13 Antibacteriële middelen. NL2000373C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22
US75326205 2005-12-22

Publications (2)

Publication Number Publication Date
NL2000373A1 true NL2000373A1 (nl) 2007-06-26
NL2000373C2 NL2000373C2 (nl) 2010-02-02

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
NL2000373A NL2000373C2 (nl) 2005-12-22 2006-12-13 Antibacteriële middelen.

Country Status (12)

Country Link
US (2) US7557100B2 (nl)
EP (2) EP1971612A1 (nl)
JP (1) JP5513743B2 (nl)
AR (1) AR058701A1 (nl)
CA (1) CA2634644A1 (nl)
DO (1) DOP2006000268A (nl)
GT (1) GT200600520A (nl)
NL (1) NL2000373C2 (nl)
PE (1) PE20071137A1 (nl)
TW (1) TW200734344A (nl)
UY (1) UY30030A1 (nl)
WO (1) WO2007072151A1 (nl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2664331B1 (en) 2003-03-10 2015-09-16 Merck Sharp & Dohme Corp. Novel Antibacterial Agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
CA2691485A1 (en) * 2007-07-02 2009-01-08 Astrazeneca Ab Chemical compounds
EP2164964B1 (en) * 2007-07-06 2011-09-07 Aarhus Universitet Dehydrated chitosan nanoparticles
KR20100066439A (ko) 2007-07-16 2010-06-17 아스트라제네카 아베 항균제로서 사용하기 위한 스피로 축합 바르비투르산 유도체
AU2008316830B2 (en) * 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
CN107854477A (zh) * 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
BR112012023950A2 (pt) 2010-03-22 2016-07-05 Cempra Pharmaceuticals Inc formas cristalinas de um macrolídeo, e usos dos mesmos
CN105198944B (zh) 2010-05-20 2018-06-01 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
KR20180110181A (ko) 2010-09-10 2018-10-08 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
RU2015138796A (ru) 2013-03-14 2017-04-19 Семпра Фармасьютикалс, Инк. Способы и составы для лечения респираторных заболеваний
KR20160020403A (ko) 2013-03-15 2016-02-23 셈프라 파마슈티컬스, 인크. 매크로라이드 항세균제들을 제조하기 위한 수렴 프로세스들
KR20170007818A (ko) 2014-05-29 2017-01-20 엔타시스 테라퓨틱스 리미티드 박테리아 감염의 치료를 위한 융합된,스피로환식 헤테로방향족 화합물
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
CN117946114A (zh) 2017-07-28 2024-04-30 武田药品工业株式会社 Tyk2抑制剂与其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
SK4972003A3 (en) 2000-10-26 2004-05-04 Pfizer Prod Inc 5-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
DE60208541D1 (de) * 2001-05-30 2006-03-30 Warner Lambert Co Antibakterielle mittel
WO2003091252A1 (en) 2002-04-25 2003-11-06 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
US20070197518A1 (en) 2007-08-23
TW200734344A (en) 2007-09-16
JP5513743B2 (ja) 2014-06-04
DOP2006000268A (es) 2007-07-31
AR058701A1 (es) 2008-02-20
EP1971612A1 (en) 2008-09-24
UY30030A1 (es) 2007-07-31
WO2007072151A1 (en) 2007-06-28
CA2634644A1 (en) 2007-06-28
PE20071137A1 (es) 2008-01-10
GT200600520A (es) 2007-07-17
US7557100B2 (en) 2009-07-07
NL2000373C2 (nl) 2010-02-02
JP2009520804A (ja) 2009-05-28
US20090275536A1 (en) 2009-11-05
EP2620439A1 (en) 2013-07-31

Similar Documents

Publication Publication Date Title
NL300935I2 (nl) guselkumab.
NL2000373A1 (nl) Antibacteriele middelen.
DK1879877T3 (da) Antimikrobielle midler
SI3670528T1 (sl) Sredstva, ki vežejo sklerostin
NL1031385A1 (nl) Gesubstitueerde sulfonylaminoarylmethylcyclopropaancarbonamideverbindingen.
EP1893244A4 (en) AGENTS FOR IMAGING
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DK1848727T3 (da) Ibandronat polymorf b
NO20051199L (no) Rorhandteringsutstyr.
NO20053362D0 (no) Syklofuge.
DE502006006589D1 (de) Teils
DE602006007836D1 (de) Kontrastmittel
ITMI20050051A1 (it) Fotodiodio organico di poli-9,9-diottil-fluorene
NO20052429D0 (no) Konstrastmidler
EP1940415A4 (en) 19,23,24,25,26,27-HEXANOR-1ALPHA-HYDROXYVITAMINE D3
ES1057865Y (es) Desatascador de desagues.
FR2884491B1 (fr) Gouvernail de secours.
ES1059608Y (es) Percha-soporte.
ES1060970Y (es) Llavero-monedero.
ES1059785Y (es) Caja-asiento.
ES1059992Y (es) Marco-estuche.
NO20052314D0 (no) Thrustertunell.
NO20052882D0 (no) Bolgekraftverk.
NO20051198D0 (no) Nokkelsystem.
NO20052152D0 (no) Bolgekraftverk.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20091130

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20110701